Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-13 4:08 pm Sale | 2026-06-30 | 13G | XENON PHARMACEUTICALS INC XENE | Wellington Management Group LLP | 1,425,492 1.500% | -3,339,287 (-70.08%) | Filing History |
| 2026-08-07 11:04 am Purchase | 2026-07-31 | 13G | XENON PHARMACEUTICALS INC XENE | FMR LLC | 9,959,795 10.300% | 360,297 (+3.75%) | Filing History |
| 2026-08-06 10:43 am Purchase | 2026-06-30 | 13G | XENON PHARMACEUTICALS INC XENE | FMR LLC | 9,599,498 9.900% | 775,135 (+8.78%) | Filing History |
| 2026-05-15 11:23 am Purchase | 2026-03-31 | 13G | XENON PHARMACEUTICALS INC XENE | JANUS HENDERSON GROUP Ltd. JHG | 4,175,982 4.500% | 232,097 (+5.88%) | Filing History |
| 2026-05-15 08:17 am Purchase | 2026-03-31 | 13G | XENON PHARMACEUTICALS INC XENE | Avoro Capital Advisors LLC | 5,777,777 6.260% | 111,111 (+1.96%) | Filing History |
| 2026-05-15 07:06 am Purchase | 2025-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | DRIEHAUS CAPITAL MANAGEMENT LLC | 4,491,653 4.870% | 146,473 (+3.37%) | Filing History |
| 2026-02-10 11:23 am Purchase | 2025-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | Wellington Management Group LLP | 4,764,779 6.200% | 2,590,018 (+119.09%) | Filing History |
| 2025-11-14 10:29 am Purchase | 2025-09-30 | 13G | XENON PHARMACEUTICALS INC XENE | JANUS HENDERSON GROUP Ltd. JHG | 3,943,885 5.100% | 3,943,885 (New Position) | Filing History |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | XENON PHARMACEUTICALS INC XENE | Wellington Management Group LLP | 2,174,761 2.800% | -1,987,893 (-47.76%) | Filing History |
| 2025-08-06 12:19 pm Purchase | 2025-06-30 | 13G | XENON PHARMACEUTICALS INC XENE | FMR LLC | 8,824,363 11.500% | 973,265 (+12.40%) | Filing History |
| 2025-07-17 7:44 pm Purchase | 2025-06-30 | 13G | XENON PHARMACEUTICALS INC XENE | BlackRock Inc. BLK | 4,757,709 6.200% | 4,757,709 (New Position) | Filing History |
| 2025-03-07 10:01 am Purchase | 2025-02-28 | 13G | XENON PHARMACEUTICALS INC XENE | FMR LLC | 7,851,098 10.300% | 983,414 (+14.32%) | Filing History |
| 2024-11-12 10:40 am Purchase | 2024-11-08 | 13G | XENON PHARMACEUTICALS INC XENE | FMR LLC | 6,867,684 9.064% | 1,211,762 (+21.42%) | Filing History |
| 2024-02-14 09:12 am Purchase | 2023-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | Avoro Capital Advisors LLC | 5,666,666 7.700% | 766,666 (+15.65%) | Filing History |
| 2024-02-14 07:43 am Sale | 2023-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | DRIEHAUS CAPITAL MANAGEMENT LLC | 4,345,180 5.880% | -336,617 (-7.19%) | Filing History |
| 2024-02-09 10:05 am Purchase | 2024-02-08 | 13G | XENON PHARMACEUTICALS INC XENE | FMR LLC | 5,655,922 7.556% | 965,093 (+20.57%) | Filing History |
| 2024-02-08 10:03 am Purchase | 2023-12-29 | 13G | XENON PHARMACEUTICALS INC XENE | Wellington Management Group LLP | 4,162,654 5.560% | 4,162,654 (New Position) | Filing History |
| 2023-02-14 4:19 pm Sale | 2022-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | Point72 Asset Management, L.P. | 1,178,501 1.900% | -1,828,637 (-60.81%) | Filing History |
| 2023-02-14 09:41 am Sale | 2022-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | Avoro Capital Advisors LLC | 4,900,000 7.800% | -85,000 (-1.71%) | Filing History |
| 2023-02-13 8:20 pm Sale | 2022-12-31 | 13G | XENON PHARMACEUTICALS INC XENE | BIOTECHNOLOGY VALUE FUND L P | 1,271,243 2.000% | -3,034,297 (-70.47%) | Filing History |